(Q73793191)
Statements
Immune function in patients with beta thalassaemia receiving the orally active iron-chelating agent deferiprone (English)
N F Olivieri
R Loebstein
I Dalal
E Nisbet-Brown
M Berkovitch
N Meydan
D Andrews
M D Loubser
1 September 1997